Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 195

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Deletion of the M 5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia

Open access
Basile, Anthony S., Fedorova, Irina, Zapata, Agustin, Liu, Xiaoguang, Shippenberg, Toni, Duttaroy, Alokesh, Yamada, Masahisa, Wess, Jürgen·2002·Proceedings of the National Academy of Sciences

Abstract

Little is known about the physiological roles of the M 5 muscarinic receptor, the last member of the muscarinic receptor family (M 1 –M 5 ) to be cloned. In the brain, the M 5 receptor subtype is preferentially expressed by dopaminergic neurons of the substantia nigra and the ventral tegmental area. Dopaminergic neurons located in the ventral tegmental area are known to play important roles in mediating both the rewarding effects of opiates and other drugs of abuse and the manifestations of opiate/drug withdrawal symptoms. We therefore speculated that acetylcholine-dependent activation of M 5 receptors might modulate the manifestations of opiate reward and withdrawal. This hypothesis was tested in a series of behavioral, biochemical, and neurochemical studies using M 5 receptor-deficient mice (M 5 −/− mice) as novel experimental tools. We found that the rewarding effects of morphine, as measured in the conditioned place preference paradigm, were substantially reduced in M 5 −/− mice. Furthermore, both the somatic and affective components of naloxone-induced morphine withdrawal symptoms were significantly attenuated in M 5 −/− mice. In contrast, the analgesic efficacy of morphine and the development of tolerance to the analgesic effects of morphine remained unaltered by the lack of M 5 receptors. The finding that M 5 receptor activity modulates both morphine reward and withdrawal processes suggests that M 5 receptors may represent a novel target for the treatment of opiate addiction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.162371899

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 31

  1. 10.1016/0896-6273(88)90190-0 · DOI · Paper page
  2. 10.1016/S0021-9258(18)83237-9 · DOI · Paper page
  3. 10.1615/CritRevNeurobiol.v10.i1.40 · DOI · Paper page
  4. Caulfield M. P. & Birdsall, N. J. M. (1998) Pharmacol. Rev.50,279-290.9647869
  5. 10.1016/S0024-3205(97)00054-4 · DOI
  6. 10.1038/sj.bjp.0703276 · DOI
  7. 10.1073/pnas.251542998 · DOI · Paper page
  8. Yasuda R. P., Ciesla, W., Flores, L. R., Wall, S. J., Li, M., Satkus, S. A., Weisstein, J. S., Spagnola, B. V. & Wolfe, B. B. (1993) Mol. Pharmacol.43,149-157.8429821
  9. 10.1016/0304-3940(90)90064-G · DOI · Paper page
  10. 10.1073/pnas.87.18.7050 · DOI · Paper page
  11. 10.1523/JNEUROSCI.22-01-j0001.2002 · DOI
  12. 10.1523/JNEUROSCI.15-09-05859.1995 · DOI · Paper page
  13. 10.1523/JNEUROSCI.16-02-00714.1996 · DOI · Paper page
  14. 10.1016/S0959-4388(96)80079-1 · DOI · Paper page
  15. Lacey M. G., Calabresi, P. & North, R. A. J. (1990) J. Pharmacol. Exp. Ther.253,395-400.2329522
  16. 10.1016/S0091-3057(96)00467-4 · DOI
  17. 10.1016/S0028-3908(99)00080-5 · doi:10.1016/s0028-3908(99)00080-5
  18. 10.1007/s002130050002 · DOI
  19. Fedorova I., Hashimoto, A., Fecik, R. A., Hedrick, M. P., Hanus, L. O., Boger, D. L., Rice, K. C. & Basile, A. S. (2001) J. Pharmacol. Exp. Ther.299,322-342.
  20. Pani A. K. Shippenberg T. S. Heidebreder C. & Espey M. G. (1997) in Current Protocols in Neuroscience eds. Crawley J. N. Gerfen C. R. Rogawski M. A. Sibley D. R. & Skolnick P. (Wiley New York).
  21. 10.1016/0165-0270(93)90097-B · DOI · Paper page
  22. 10.1002/1098-2396(200008)37:2<118::AID-SYN6>3.0.CO;2-2 · doi:10.1002/1098-2396(200008)37:2<118::aid-syn6>3.0.co;2-2
  23. 10.1046/j.1471-4159.1995.65031124.x · DOI
  24. 10.1073/pnas.96.18.10483 · DOI · Paper page
  25. Nye H. E. & Nestler, E. J. (1996) Mol. Pharmacol.49,636-645.8609891
  26. 10.1016/S0301-0082(98)00060-4 · DOI · Paper page
  27. 10.1038/41567 · DOI · Paper page
  28. 10.1038/35012069 · DOI · Paper page
  29. 10.1615/CritRevNeurobiol.v12.i4.10 · DOI
  30. 10.1523/JNEUROSCI.20-23-08861.2000 · DOI
  31. O'Brien C. P. (2001) in The Pharmacological Basis of Therapeutics eds. Hardman J. G. & Limbird L. E. (McGraw-Hill New York) pp. 621–642.

Cited by

See all 195

Metadata

Authors
Basile, A. S., Fedorova, I., Zapata, A., Liu, X., Shippenberg, T., Duttaroy, A., Yamada, M., & Wess, J.
Venue
Proceedings of the National Academy of Sciences
Published
2002-08
Volume
99
Issue
17
Pages
11452-11457
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2028310558
Cited by
195
References
5
FWCI
3.20
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deletion of the M 5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. https://app.cochat.ai/papers/10.1073/pnas.162371899
The paper
Basile, A. S., Fedorova, I., Zapata, A., Liu, X., Shippenberg, T., Duttaroy, A., Yamada, M., & Wess, J. (2002). Deletion of the M 5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.162371899

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.